'Idiopathic' FSGS: An increasingly obsolete diagnosis?

Nephrology Dialysis Transplantation

Volumn 25, Issue 3, 2010, Pages 654-656

  Yang, Hai Chun ^a   Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

FSGS; Gene mutation; Podocyte

Indexed keywords

ACTIN BINDING PROTEIN; ALPHA ACTININ 4; CD2 ASSOCIATED PROTEIN; NEPHRIN; PODOCIN;

CHROMOSOME; DISEASE ASSOCIATION; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; KIDNEY FAILURE; NEPHROTIC SYNDROME; NONHUMAN; NOTE; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEINURIA;

ACTININ; ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MICE; MICROFILAMENT PROTEINS; MUTATION; PROMOTER REGIONS, GENETIC;

EID: 77649199966     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp750     Document Type: Note

References (22)

1. Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004; 44: 815-825
2. Winn MP, Conlon PJ, Lynn KL, et al. Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics 1999; 58: 113-120
3. Conlon PJ, Butterly D, Albers F, et al. Clinical and pathologic features of familial focal segmental glomerulosclerosis. Am J Kidney Dis 1995; 26: 34-40
4. Verani RR, Conley SB. Sickle cell glomerulopathy with focal segmental glomerulosclerosis. Child Nephrol Urol 1991; 11: 206-208
5. Winn MP, Conlon PJ, Lynn KL, et al. Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glo-merulosclerosis. Kidney Int 1999; 55: 1241-1246
6. Weins A, Kenlan P, Herbert S, et al. Mutational and biological analysis of alpha-actinin-4 in focal segmental glomerulosclerosis. J Am Soc Nephrol 2005; 16: 3694-3701
7. Dai S, Wang Z, Pan X, et al. Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis. Nephrol Dial Transplant 2010; 25: 824-835
8. Boute N, Gribouval O, Roselli S, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant ne-phrotic syndrome. Nat Genet 2000; 24: 349-354
9. Hinkes B, Vlangos C, Heeringa S, et al. Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2008; 19: 365-371
10. Tsukaguchi H, Sudhakar A, Le TC, et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 2002; 110: 1659-1666
11. Kaplan JM, Kim SH, North KN, et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclero-sis. Nat Genet 2000; 24: 251-256
12. Winn MP, Conlon PJ, Lynn KL, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308: 1801-1804
13. McKenzie LM, Hendrickson SL, Briggs WA, et al. NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol 2007; 18: 2987-2995
14. Dai S, Wang Z, Pan X, et al. ACTN4 gene mutations and single nucle-otide polymorphisms in idiopathic focal segmental glomerulosclero-sis. Nephron Clin Pract 2009; 111: c87-c94
15. Michaud JL, Lemieux LI, Dube M, et al. Focal and segmental glo-merulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J Am Soc Nephrol 2003; 14: 1200-1211
16. Komatsuda A, Wakui H, Maki N, et al. Analysis of mutations in alpha-actinin 4 and podocin genes of patients with chronic renal failure due to sporadic focal segmental glomerulosclerosis. Ren Fail 2003; 25: 87-93
17. Lowik M, Levtchenko E, Westra D, et al. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclero-sis. Nephrol Dial Transplant 2008; 23: 3146-3151
18. Huber TB, Kwoh C, Wu H, et al. Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest 2006; 116: 1337-1345
19. Yao J, Le TC, Kos CH, et al. Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol 2004; 2: e167
20. Ruf RG, Lichtenberger A, Karle SM, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004; 15: 722-732
21. Caridi G, Gigante M, Ravani P, et al. Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. Clin J Am Soc Nephrol 2009; 4: 1065-1072
22. Pollak MR. The genetic basis of FSGS and steroid-resistant nephro-sis. Semin Nephrol 2003; 23: 141-146